Compile Data Set for Download or QSAR
Found 13 of ec50 data for polymerid = 2012,2046
TargetProcathepsin L(Homo sapiens (Human))
Merck Frosst Centre for Therapeutic Research

LigandPNGBDBM19855(Balicatib | CHEMBL371064 | N-[1-(cyanomethylcarbam...)copy SMILEScopy InChI
Affinity DataIC50: 503nM EC50:  48nMpH: 5.5 T: 2°CAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q28S4N63PubMed
TargetProcathepsin L(Homo sapiens (Human))
Merck Frosst Centre for Therapeutic Research

LigandPNGBDBM23866(MDL28170 | Z-Val-Phe-CHO | benzyl N-[(1S)-2-methyl...)copy SMILEScopy InChI
Affinity DataEC50:  100nMAssay Description:This is a review article.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JS9ST6PubMed
TargetProcathepsin L(Homo sapiens (Human))
Merck Frosst Centre for Therapeutic Research

LigandPNGBDBM429284(med.21724, Compound 22)copy SMILES
Affinity DataEC50:  193nMAssay Description:This is a review article.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JS9ST6PubMed
TargetProcathepsin L(Homo sapiens (Human))
Merck Frosst Centre for Therapeutic Research

LigandPNGBDBM19859((2S)-N-(cyanomethyl)-3-cyclohexyl-2-(phenylformami...)copy SMILEScopy InChI
Affinity DataIC50: 55nM EC50:  230nMpH: 5.5 T: 2°CAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q28S4N63PubMed
TargetProcathepsin L(Homo sapiens (Human))
Merck Frosst Centre for Therapeutic Research

LigandPNGBDBM19856((2R)-N-(cyanomethyl)-4-methyl-2-{3-[4-(piperazin-1...)copy SMILEScopy InChI
Affinity DataIC50: 2.60E+3nM EC50:  320nMpH: 5.5 T: 2°CAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q28S4N63PubMed
TargetProcathepsin L(Homo sapiens (Human))
Merck Frosst Centre for Therapeutic Research

LigandPNGBDBM19854(CHEMBL426819 | CRA-013783/L-006235 | N-{1-[(cyanom...)copy SMILEScopy InChI
Affinity DataIC50: 6.30E+3nM EC50:  340nMpH: 5.5 T: 2°CAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q28S4N63PubMed
TargetProcathepsin L(Homo sapiens (Human))
Merck Frosst Centre for Therapeutic Research

LigandPNGBDBM429290(med.21724, Compound 26)copy SMILEScopy InChI
Affinity DataEC50:  1.60E+3nMAssay Description:This is a review article.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JS9ST6PubMed
TargetProcathepsin L(Homo sapiens (Human))
Merck Frosst Centre for Therapeutic Research

LigandPNGBDBM50176994(CHEMBL3813784)copy SMILEScopy InChI
Affinity DataEC50:  6.00E+3nMAssay Description:Activation of human liver cathepsin L using Z-FR-AMC as substrate measured for 120 mins by fluorescence assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2FN184PPubMed
TargetProcathepsin L(Homo sapiens (Human))
Merck Frosst Centre for Therapeutic Research

LigandPNGBDBM50376204(CHEMBL401925 | med.21724, Compound 23)copy SMILEScopy InChI
Affinity DataEC50:  6.40E+3nMAssay Description:This is a review article.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JS9ST6PubMed
TargetProcathepsin L(Homo sapiens (Human))
Merck Frosst Centre for Therapeutic Research

LigandPNGBDBM429289(med.21724, Compound 25)copy SMILEScopy InChI
Affinity DataEC50:  9.70E+3nMAssay Description:This is a review article.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JS9ST6PubMed
TargetProcathepsin L(Homo sapiens (Human))
Merck Frosst Centre for Therapeutic Research

LigandPNGBDBM19857(N-{1-[(cyanomethyl)carbamoyl]cyclohexyl}-4-[2-(mor...)copy SMILEScopy InChI
Affinity DataIC50: 2.40E+4nM EC50: >1.00E+4nMpH: 5.5 T: 2°CAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q28S4N63PubMed
TargetProcathepsin L(Homo sapiens (Human))
Merck Frosst Centre for Therapeutic Research

LigandPNGBDBM19858(N-{1-[(cyanomethyl)carbamoyl]cyclohexyl}-4-(morpho...)copy SMILEScopy InChI
Affinity DataIC50: 3.20E+4nM EC50: >1.00E+4nMpH: 5.5 T: 2°CAssay Description:Prior to the addition of substrate, different concentrations of the inhibitor ranging from 100 uM to 0.2 nM were preincubated for 15 min with enzyme ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q28S4N63PubMed
TargetProcathepsin L(Homo sapiens (Human))
Merck Frosst Centre for Therapeutic Research

LigandPNGBDBM11318(1,3,8-trihydroxy-6-methyl-9,10-dihydroanthracene-9...)copy SMILEScopy InChI
Affinity DataEC50:  2.00E+5nMAssay Description:This is a review article.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2JS9ST6PubMed